SCHEMBL28024

SCHEMBL28024

C1CCC2(C1)CCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1372723 0.97 TSHR (0.38)
SCHEMBL27414429 0.97 TSHR (0.38)
SCHEMBL1829807 0.97 TSHR (0.38)
Hydrochloric Acid SCHEMBL1372820 0.94 TSHR (0.41)
Hydrochloric Acid SCHEMBL8741359 0.94 TSHR (0.41)
SCHEMBL1794983 0.94
SCHEMBL5438837 0.92 ALDH1A1 (0.40)
Hydrochloric Acid SCHEMBL15772686 0.91
SCHEMBL5431132 0.89 ALDH1A1 (0.38)
SCHEMBL503843 0.88 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4298095-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITOR AND USES THEREOF Sperogenix Therapeutics Limited (HK) 2024-01-03 EP claimed
WO-2022162606-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITOR AND USES THEREOF SPEROGENIX THERAPEUTICS LIMITED (CN) 2022-08-04 WO claimed
EP-4010335-A1 SHP2 INHIBITORS IRBM S.P.A. (IT) 2022-06-15 EP claimed
WO-2021028362-A1 SHP2 INHIBITORS IRBM S.P.A. (IT) 2021-02-18 WO claimed
EP-2822941-A1 BENZODIOXANES IN COMBINATION WITH OTHER ACTIVES FOR INHIBITING LEUKOTRIENE PRODUCTION Boehringer Ingelheim International GmbH (DE) 2015-01-14 EP claimed
WO-2013131901-A1 BENZODIOXANES IN COMBINATION WITH OTHER ACTIVES FOR INHIBITING LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-09-12 WO claimed
JP-4749715-B2 2011-08-17 JP claimed
JP-2011509933-A 2011-03-31 JP claimed
EP-2242364-A1 PREPARATION AND ENANTIOMERIC SEPARATION OF 7-(3-PYRIDINYL)-1,7-DIAZASPIROÝ4.4¨NONANE AND NOVEL SALT FORMS OF THE RACEMATE AND ENANTIOMERS Targacept Inc. (US) 2010-10-27 EP claimed
WO-2009091561-A1 PREPARATION AND ENANTIOMERIC SEPARATION OF 7-(3-PYRIDINYL)-1,7-DIAZASPIRO[4.4] NONANE AND NOVEL SALT FORMS OF THE RACEMATE AND ENANTIOMERS TARGACEPT, INC. (US) 2009-07-23 WO claimed
EP-0307872-A2 Esters of amino-acids, process for their preparation, medicaments containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-03-22 EP claimed
EP-0265685-A2 Combination of ACE inhibitors with calcium antagonists, and their use in medicines HOECHST AKTIENGESELLSCHAFT (DE) 1988-05-04 EP claimed
EP-0243645-A2 Compounds having a nootropic activity, agents containing them and their use in the treatment and prophylaxis of cognitive malfunctions HOECHST AKTIENGESELLSCHAFT (DE) 1987-11-04 EP claimed
EP-0126986-B1 PROCESS FOR PRODUCING N-ALKYLATED DIPEPTIDES AND THEIR ESTERS HOECHST AKTIENGESELLSCHAFT (DE) 1987-08-05 EP claimed
EP-0219782-A2 Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-29 EP claimed
EP-0158157-A1 Method for the treatment of glaucoma HOECHST AKTIENGESELLSCHAFT (DE) 1985-10-16 EP claimed
US-4525301-A REACTING TRIFLUOROMETHANE SULFONIC ACID DERIVATIVES WITH AMINO ACID ESTERS HOECHST AKTIENGESELLSCHAFT (DE) 1985-06-25 US claimed
EP-0135182-A2 Process for the production of N-alkylated dipeptides and of their esters HOECHST AKTIENGESELLSCHAFT (DE) 1985-03-27 EP claimed
EP-0135181-A2 Process for the production of N-alkylated dipeptides and of their esters HOECHST AKTIENGESELLSCHAFT (DE) 1985-03-27 EP claimed
EP-0126986-A1 Process for producing N-alkylated dipeptides and their esters HOECHST AKTIENGESELLSCHAFT (DE) 1984-12-05 EP claimed